Atellica CH AlbP 11097530Recalls & reported problems
Siemens Healthcare Diagnostics Inc. · Albumin BCP (AlbP) Atellica CH - RGT 6400T · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00630414595825), received between Dec 27, 2024 and Dec 27, 2024 — classified as 1 malfunction.
The most frequently reported specific device problem is “Low Test Results” (1 report).
12 other recalls cover devices cleared under the same FDA submission (K151767); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Low Test Results1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 27, 2024Low Test Results; Low Test Results
THE CUSTOMER REPORTED TO SIEMENS THEY OBTAINED ERRONEOUSLY DEPRESSED ALBUMIN BCP (ALBP) RESULTS ON THREE (3) PATIENT SAMPLES WHEN PROCESSED ON AN ATELLICA CH 930 ANALYZER. TWO OF THE PATIENT SAMPLE RESULTS WERE REPORTED TO THE PHYSICIAN AND QUESTIONED. THE PATIENT SAMPLES WERE REPROCESSED ON AN ALTERNATE ATELLICA CH 930 ANALYZER. HIGHER RESULTS WERE OBTAINED, CONSIDERED CORRECT, AND REPORTED TO THE PHYSICIAN. THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE ERRONEOUSLY DEPRESSED ALBUMIN BCP (ALBP) RESULTS.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21029236 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K151767. One submission often covers many models, so check the product and lot details in each record.
- Z-2027-2025 · May 22, 2025 · Open, ClassifiedProduct: Atellica CH Diluent - CONS 2 x 1.5L; Siemens Material Number (SMN): 11099300;
- Z-1003-2024 · Dec 15, 2023 · Open, ClassifiedTotal immunoglobulin M (IgM total) IVD, kit, nephelometry/turbidimetry
- Z-0449-2022 · Nov 18, 2021 · Open, ClassifiedAtellica CH 930 Analyzer with Software version: V1.25.1 and lower- An automated, clinical chemistry analyzer designed to perform in vitro diagnostic tests on clinical specimens. S
- Z-2026-2021 · May 13, 2021 · Open, ClassifiedAtellica CH 930 Analyzer - multi-component system for in vitro diagnostic testing of clinical specimens SMN 11067000
- Z-1870-2021 · May 4, 2021 · Open, ClassifiedAtellica CH 930 Analyzer with Photometer Lamp (SMN 11075676) Siemens Material Number: 11067000
- Z-0861-2021 · Dec 2, 2020 · TerminatedAtellica CH 930 Analyzer - In vitro diagnostic testing of clinical specimens. Product Siemens Material Number (SMN): 11067000 - Product Usage: intended for the qualitative and quan
- Z-1797-2020 · Feb 27, 2020 · TerminatedAtellica CH 930 Analyzer, Siemens Material Number 11067000 with software version v1.21.0 SP1 or lower
- Z-0862-2020 · Oct 11, 2019 · TerminatedAtellica CH 930 Analyzer, Siemens Material Number 11067000, Software Versions V1.19.2 or 1.20.0 The Atellica CH 930 Analyzer is an automated, clinical chemistry analyzer designed
- Z-0581-2020 · Sep 23, 2019 · TerminatedAtellica CH 930 Analyzer
- Z-0148-2020 · Jul 30, 2019 · TerminatedSiemens Atellica CH 930 Analyzer. Siemens Material Number (SMN): 11067000 Product Usage: automated, clinical chemistry analyzer to perform in vitro diagnostic tests on clini
- Z-0782-2019 · Sep 26, 2018 · TerminatedAtellica CH 930 Analyzer. In vitro diagnostic testing of clinical specimens Siemens Material Number (SMN): 1 067000 - Product Usage: The Atellica Solution is a multi-component s
- Z-0194-2019 · Jun 29, 2018 · TerminatedAtellica CH 930 Analyzer (SMN 11067000) . The Atellica" Solution is a multi-component system for in vitro diagnostic testing of clinical specimens.
Other BROMCRESOL PURPLE DYE-BINDING, ALBUMIN devices
- Dimension® Flex® reagent cartridge ALB 10444975Siemens Healthcare Diagnostics Inc. · BROMCRESOL PURPLE DYE-BINDING, ALBUMIN6 reports
- Albumin BCP 5975573190Roche Diagnostics GmbH · BROMCRESOL PURPLE DYE-BINDING, ALBUMIN1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page